Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Net Margin (2017 - 2025)

Historic Net Margin for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to 6.87%.

  • Selectis Health's Net Margin rose 229900.0% to 6.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.94%, marking a year-over-year increase of 124500.0%. This contributed to the annual value of 6.19% for FY2024, which is 46800.0% up from last year.
  • According to the latest figures from Q3 2025, Selectis Health's Net Margin is 6.87%, which was up 229900.0% from 3.02% recorded in Q2 2025.
  • Selectis Health's Net Margin's 5-year high stood at 41.83% during Q1 2023, with a 5-year trough of 39.56% in Q4 2023.
  • Its 5-year average for Net Margin is 6.24%, with a median of 6.4% in 2025.
  • In the last 5 years, Selectis Health's Net Margin skyrocketed by 395600bps in 2023 and then crashed by -528100bps in 2024.
  • Selectis Health's Net Margin (Quarter) stood at 17.42% in 2021, then dropped by -17bps to 20.37% in 2022, then plummeted by -94bps to 39.56% in 2023, then skyrocketed by 86bps to 5.54% in 2024, then surged by 224bps to 6.87% in 2025.
  • Its Net Margin was 6.87% in Q3 2025, compared to 3.02% in Q2 2025 and 6.4% in Q1 2025.